Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
出版年份 2022 全文链接
标题
Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
作者
关键词
-
出版物
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-27
DOI
10.1007/s00210-022-02243-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
- (2021) Pardeep S. Jhund et al. CIRCULATION
- The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
- (2021) Vincenzo Quagliariello et al. Cardiovascular Diabetology
- Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway
- (2021) Xiu‐Juan Liu et al. FEBS Open Bio
- Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis
- (2021) Dong Ning et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the long non‐coding RNA ZFAS1 attenuates ferroptosis by sponging miR‐150‐5p and activates CCND2 against diabetic cardiomyopathy
- (2021) Tingjuan Ni et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure
- (2021) Yu Zheng et al. Frontiers in Cardiovascular Medicine
- Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury
- (2020) Chunyan Wang et al. Molecular Medicine Reports
- Evaluation and management of heart failure with preserved ejection fraction
- (2020) Barry A. Borlaug Nature Reviews Cardiology
- Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats
- (2020) Marina Krasnova et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*
- (2020) Nathalie Percie du Sert et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload
- (2020) Junyan Wang et al. Cell Death & Disease
- Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
- (2020) Angelamellisy Ndibalema et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
- (2020) Tomonori Tadokoro et al. JCI Insight
- NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
- (2019) Matthew Dodson et al. Redox Biology
- Ferroptosis as a target for protection against cardiomyopathy
- (2019) Xuexian Fang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
- (2019) Hsiang-Chun Lee et al. Cardiovascular Diabetology
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction
- (2019) Nannan Zhang et al. Cardiovascular Diabetology
- Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
- (2019) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathy
- (2019) Toshiyuki Takasu et al. LIFE SCIENCES
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
- (2019) Paul J. Derry et al. PROGRESS IN NEUROBIOLOGY
- Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes
- (2019) Tae-Jun Park et al. Cell Death & Disease
- NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
- (2019) Moritz Schnelle et al. CARDIOVASCULAR RESEARCH
- Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes
- (2018) Yuichi Baba et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis
- (2018) Bei Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
- (2018) Concetta Irace et al. Cardiovascular Diabetology
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Underestimated prevalence of heart failure in hospital inpatients: a comparison of ICD codes and discharge letter information
- (2018) Mathias Kaspar et al. Clinical Research in Cardiology
- Iron status and oxidative stress in the aged rabbit heart
- (2018) Domenico Lapenna et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
- (2018) Huizhong Feng et al. PLOS BIOLOGY
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
- (2017) Pongpan Tanajak et al. JOURNAL OF ENDOCRINOLOGY
- ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
- (2016) Sebastian Doll et al. Nature Chemical Biology
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- Glutaminolysis and Transferrin Regulate Ferroptosis
- (2015) Minghui Gao et al. MOLECULAR CELL
- Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
- (2015) Samira Lakhal-Littleton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart
- (2015) Wenjing Xu et al. Cell Reports
- Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
- (2014) William L. Baker et al. Journal of the American Society of Hypertension
- Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
- (2014) Jose Pedro Friedmann Angeli et al. NATURE CELL BIOLOGY
- Cardiac Involvement in Hemochromatosis
- (2013) Vinay Gulati et al. Cardiology in Review
- Iron Metabolism, Hepcidin, and Anemia in Orthotopic Heart Transplantation Recipients Treated with Mammalian Target of Rapamycin
- (2013) P. Przybylowski et al. TRANSPLANTATION PROCEEDINGS
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- mTOR Regulates Cellular Iron Homeostasis through Tristetraprolin
- (2012) Marina Bayeva et al. Cell Metabolism
- Iron homeostasis in osteoporosis and its clinical implications
- (2012) G. F. Li et al. OSTEOPOROSIS INTERNATIONAL
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2012) VETERINARY CLINICAL PATHOLOGY
- Effect of High Fat Loading in Dahl Salt-Sensitive Rats
- (2009) Ai Nagae et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation